ANIX Should I Buy

ANIX is not a good buy right now for a beginner, long-term investor with $50k–$100k who is impatient about entry timing. The stock is in a bearish technical structure (SMA_200 > SMA_20 > SMA_5) near support, the company is still pre-revenue with widening losses in 2025/Q4, and options are extremely speculative (very high IV). Despite a positive patent catalyst and strong insider buying, the overall setup is better suited to high-risk biotech speculation than a beginner long-term allocation today.

Pre-market price is ~3.03, sitting just above key support S1 at 3.012 (next S2 at 2.91). Trend remains bearish with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating the longer-term downtrend is still intact. MACD histogram is positive (0.0243) but contracting, suggesting upside momentum is fading rather than accelerating. RSI_6 at 35.63 is weak/near-oversold territory, which can allow for a bounce, but it is not a strong trend-reversal signal by itself. Key levels: pivot resistance ~3.179; then R1 3.345 and R2 3.447. With price below the pivot and under bearish MAs, rallies are more likely to face selling pressure. Pattern-based stats also point to mild near-term downside (-1.09% next day, -1.06% next week) with only modest improvement over a month (+1.36%).